S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
Is CRISPR Therapeutics the NVIDIA of gene editing?
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
3 Chinese stocks poised for rebound
4 stocks benefitting from NVIDIA's explosive growth
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
These 2 carnivore dining stocks gaining on the Ozempic craze
This healthcare stock making a buzz with 160% growth
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
First it was Tyson stock, now this food company is set to rally
How major US stock indexes fared Monday, 2/26/2024
S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
Is CRISPR Therapeutics the NVIDIA of gene editing?
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
3 Chinese stocks poised for rebound
4 stocks benefitting from NVIDIA's explosive growth
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
These 2 carnivore dining stocks gaining on the Ozempic craze
This healthcare stock making a buzz with 160% growth
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
First it was Tyson stock, now this food company is set to rally
How major US stock indexes fared Monday, 2/26/2024
S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
Is CRISPR Therapeutics the NVIDIA of gene editing?
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
3 Chinese stocks poised for rebound
4 stocks benefitting from NVIDIA's explosive growth
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
These 2 carnivore dining stocks gaining on the Ozempic craze
This healthcare stock making a buzz with 160% growth
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
First it was Tyson stock, now this food company is set to rally
How major US stock indexes fared Monday, 2/26/2024
S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
Is CRISPR Therapeutics the NVIDIA of gene editing?
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
3 Chinese stocks poised for rebound
4 stocks benefitting from NVIDIA's explosive growth
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
These 2 carnivore dining stocks gaining on the Ozempic craze
This healthcare stock making a buzz with 160% growth
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
First it was Tyson stock, now this food company is set to rally
How major US stock indexes fared Monday, 2/26/2024
OTCMKTS:JUSHF

Jushi (JUSHF) Stock Price, News & Analysis

$0.75
-0.05 (-6.23%)
(As of 02/26/2024 ET)
Today's Range
$0.75
$0.85
50-Day Range
$0.42
$0.98
52-Week Range
$0.35
$1.09
Volume
201,745 shs
Average Volume
415,372 shs
Market Capitalization
$147.87 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Jushi MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
1.10% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.28mentions of Jushi in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.27) to ($0.20) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.73 out of 5 stars


JUSHF stock logo

About Jushi Stock (OTCMKTS:JUSHF)

Jushi Holdings Inc., a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of medical and adult-use products. It focuses on building a portfolio of cannabis assets in various jurisdictions in Pennsylvania, Virginia, Ohio, Illinois, California, Nevada, and Massachusetts. The company also offers hemp-based CBD products, including cannabis dry flower, vaporizer forms of cannabis, edibles, cannabis oil in capsules, tinctures, cannabis in topical products, and other cannabis products, as well as vape cartridges, disposables, and concentrates under The Bank, The Lab, Nira+ Medicinals, Sèchè, Tasteology, and Hijinks brands. In addition, it operates medical cannabis dispensaries under the BEYOND/HELLO, Nature's Remedy, and NuLeaf brands. The company is headquartered in Boca Raton, Florida.

JUSHF Stock Price History

JUSHF Stock News Headlines

This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Sekisui Jushi Corp 4212
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
Jushi Holdings Inc JUSH
China Jushi Co. Ltd. A
Jushi Holdings Inc (JUSH)
Jushi Holdings Inc. Announces Option Re-Pricing Program
Jushi Holdings Inc JUSHF
See More Headlines
Receive JUSHF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Jushi and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/11/2023
Today
2/26/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medicinals & botanicals
Sub-Industry
N/A
Current Symbol
OTCMKTS:JUSHF
Fax
N/A
Employees
1,486
Year Founded
N/A

Profitability

Net Income
$-202,320,000.00
Pretax Margin
-58.11%

Debt

Sales & Book Value

Annual Sales
$284.28 million
Book Value
$0.23 per share

Miscellaneous

Free Float
155,280,000
Market Cap
$147.87 million
Optionable
Not Optionable
Beta
N/A
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

  • Mr. James Anthony Cacioppo (Age 61)
    Founder, Chairman & CEO
    Comp: $1.78M
  • Mr. Louis Jonathan Barack (Age 46)
    Founder & President
    Comp: $424.99k
  • Mr. Erich Mauff (Age 56)
    Founder, Head of Investor Relations & Chief Investment Director
    Comp: $175k
  • Ms. Michelle O. Mosier (Age 59)
    CFO & Chief Accounting Officer
  • Mr. Ryan Cook
    Executive Vice President of Operations
  • Mr. Ian Farrell
    Vice President of Compliance
  • Ms. Tobi Lebowitz (Age 43)
    Chief Legal Officer & Corporate Secretary
  • Mr. Trenton Woloveck (Age 39)
    Chief Strategy Director
    Comp: $544.17k
  • Mr. Matthew Leeth
    Executive Vice President of Legal Affairs
  • Mr. Andreas Neumann
    Chief Creative Director














JUSHF Stock Analysis - Frequently Asked Questions

Should I buy or sell Jushi stock right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Jushi in the last twelve months. There are currently 4 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" JUSHF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in JUSHF, but not buy additional shares or sell existing shares.
View JUSHF analyst ratings
or view top-rated stocks.

How have JUSHF shares performed in 2024?

Jushi's stock was trading at $0.46 at the beginning of the year. Since then, JUSHF shares have increased by 63.5% and is now trading at $0.7520.
View the best growth stocks for 2024 here
.

How were Jushi's earnings last quarter?

Jushi Holdings Inc. (OTCMKTS:JUSHF) released its quarterly earnings results on Friday, August, 11th. The company reported ($0.07) earnings per share for the quarter, topping the consensus estimate of ($0.08) by $0.01. The firm earned $66.43 million during the quarter, compared to the consensus estimate of $64.82 million. Jushi had a negative trailing twelve-month return on equity of 614.11% and a negative net margin of 67.16%.

How do I buy shares of Jushi?

Shares of JUSHF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:JUSHF) was last updated on 2/27/2024 by MarketBeat.com Staff